Ming-Cheh CHEN, MD
Buddhist Tzu Chi General Hospital
4
4
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
xiaojiao Li
The First Hospital of Jilin University
Shared therapeutic areas:
David Y Graham, MD
Baylor College of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Xiuli Zuo, MD,PhD
Qilu Hospital of Shandong University
Shared therapeutic areas:
Eun Jung Jeon
The Catholic University of Korea
Shared therapeutic areas:
Jyh-Ming Liou, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Il Ju Choi, M.D., Ph.D.
National Cancer Center, Korea
Shared therapeutic areas:
Ming-Shiang Wu, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jyh-Chin Yang, M.D.Ph.D.
National Taiwan University Hospital
Shared therapeutic areas:
Hyun Jeong Lee, fellow
Yeouido St. Mary's Hospital, The Catholic University of Korea
Shared therapeutic areas:
Ivan FN Hung, MD FRCP
The University of Hong Kong
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori
Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori
All 4 trials loaded